News
The success of PRAISE-U is dependent on clear and transparent communication between actors. As such, all publications related to the project can be reviewed and shared to promote full understanding of the project and the sharing of important data between stakeholders.
Risk-stratified Approach to Implementing Population-based Prostate Cancer Screening in Five Pilot Sites in the European Union: A Protocol for the PRAISE-U Project
This paper, published in European Urology Open Science, sets out the design of a multicentric study that aims to pilot the implementation of a risk-stratified population-based PCa screening algorithm in different health systems to generate evidence for feasibility, efficacy, and cost-effectiveness at the EU level. In addition to risk stratification, the pilot utilises MRI to refine patient selection for biopsy and is designed to address various aspects of delivery of PCa screening within an organised framework, including evidence-based management of the PCa cases detected through the project. This initiative will identify implementation strategies that are appropriate in local context in the five pilot sites.
Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium
This systematic review sheds light on significant variations in the approach to PSAbased early detection for prostate cancer across different European countries, with high levels of opportunistic screening. The suggested policy recommendations aim to promote standardised guidelines, risk-adapted screening, informed decision-making, and increased awareness to enhance the effectiveness and efficiency of prostate cancer early detection in the European Union.
Prostate Cancer Early Detection in the European Union and UK
This review of 26 reviews by the PRAISE-U consortium covers various aspects of prostate cancer screening such as invitation, decision-making, screening tests, harms, and benefits. This review provides insights into existing evidence, highlighting the areas of consensus and discrepancies, to guide future research and improve prostate cancer screening strategies in Europe.
PRAISE-U project presents to the National Societies in Noordwijk
Read more about the progress made in Noordwijk.
Implications of EU Council recommendations on Prostate Cancer Screening
Read about how changes to the EU Council recommendations are shaping PCa screening in Europe.
Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs
The landscape of PCa screening has undergone transformative shifts, particularly with the advent of screening initiatives endorsed by the EU, creating a new strategy which optimizes the early detection of clinically significant cancers as well as mitigating the risk of overdiagnosis and overtreatment
Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U
Read about the role of PRAISE-U.
Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe
This is a systematic review aimed to provide a contemporary overview of the costs and benefits of Prostate Cancer screening programmes.
Understanding the Barriers to Prostate Cancer Population-based Early Detection Programmes: The PRAISE-U BEST Survey
Read more about the diverse barriers to PCa screening faced by countries across Europe
Why is there a need to re-think Prostate Cancer early detection?
Read this abstract on the evidence on the need for PCa Early detection.
PRAISE U – a new era in risk-based screening for Prostate Cancer in the EU
Read this abstract discussing the PRAISE-U project
February 2024 PRAISE-U updates
Read articles published on updates from PRAISE-U
Article: July 2023 Praise-U Update
Read about the progress of the Praise-U project
Press Release
Read about the launch of PRAISE-U and what can be expected from the project.
About PRAISE-U
In direct partnership with a network of consortium members, PRAISE-U works to encourage early detection and diagnosis of prostate cancer through customised and risk-based screening programmes.